HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

rimonabant

a potent & selective antagonist of the brain cannabinoid receptor; structure given in first source
Also Known As:
Acomplia; N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide hydrochloride; SR 141716; SR 141716A; SR-141716A; SR141716; SR141716A; Sanofi-Synthelabo brand of rimonabant; Zimulti
Networked: 673 relevant articles (91 outcomes, 152 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Després, Jean-Pierre: 11 articles (07/2011 - 11/2005)
2. Bifulco, Maurizio: 10 articles (06/2015 - 10/2004)
3. Kim, Jeongmin: 10 articles (02/2010 - 04/2008)
4. Lee, Jinhwa: 10 articles (02/2010 - 04/2008)
5. Lee, Sung-Han: 10 articles (02/2010 - 04/2008)
6. Di Marzo, Vincenzo: 9 articles (11/2013 - 12/2002)
7. Seo, Hee Jeong: 9 articles (02/2010 - 04/2008)
8. Scheen, André J: 9 articles (02/2009 - 04/2005)
9. Laezza, Chiara: 8 articles (06/2015 - 10/2004)
10. Jung, Myung Eun: 8 articles (02/2010 - 04/2008)

Related Diseases

1. Obesity
2. Weight Loss (Weight Reduction)
3. Body Weight (Weight, Body)
4. Insulin Resistance
5. Overweight

Related Drugs and Biologics

1. CB1 Cannabinoid Receptor (CB1 Receptor)
2. Glucose (Dextrose)
3. Triglycerides (Triacylglycerol)
4. HDL Cholesterol
5. rimonabant
6. Endocannabinoids (Endocannabinoid)
7. Insulin (Novolin)
8. Cholesterol
9. Cannabinoid Receptors (Cannabinoid Receptor)
10. Lipids

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Caloric Restriction
3. Self Administration (Administration, Self)
4. Ganglionectomy
5. Vagotomy